Paying user area
Try for free
Stryker Corp. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Stryker Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
12 months ended: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||||||||
Orthopaedics and Spine | |||||||||||
Net sales |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
- Revenue Overview
- The overall net sales demonstrated a positive trend between 2019 and 2021. Starting from $14,884 million in 2019, sales slightly decreased to $14,351 million in 2020, followed by a notable recovery and increase to $17,108 million in 2021.
- Segment: MedSurg and Neurotechnology
- This segment exhibited a modest decline from 2020 to 2021, with revenues decreasing from $8,475 million to $8,345 million. However, the value rebounded in 2021 to $9,538 million, indicating a period of volatility but overall growth across the two years.
- Segment: Orthopaedics and Spine
- The Orthopaedics and Spine segment showed a decline from 2019 to 2020, with revenue decreasing from $6,409 million to $6,006 million. This was followed by a substantial increase to $7,570 million in 2021, mirroring recovery trends seen in the overall net sales figures.
- Trends and Insights
- Both key business segments experienced a dip in revenue in 2020, which coincides with global economic challenges during that period. Nevertheless, a strong rebound occurred in 2021, surpassing previous revenue peaks. This suggests effective strategic adjustments or market recovery in that timeframe. The combined growth in segments contributed to the overall increase in net sales from 2020 to 2021.